Telmobistat's first localized device in China has been approved
2026-11-18 16:19:05
According to CoinMeta, the trimaaccel ™ blood component separator produced locally in China by Terumo Becton Dickinson has obtained a medical device registration certificate issued by the National Medical Products Administration. This is the first medical device to be locally produced in China since the company announced its localization plan in 2024.
Bullish 0
Bearish 0
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.